IFNL4 and hepatocellular carcinoma: We observed a moderately increased risk of progression to HCC in HCV patients with IFNL4 genotype in the general population, but this risk was eliminated in patients achieving viral clearance, explaining inconsistencies in previous reports on HCC risk (10–15).